Prof. Stefan Buchholz to head Evonik's R&D group Creavis

Prof. Stefan Buchholz (50) has assumed the position as head of Creavis, the strategic R&D unit of Evonik. Buchholz studied chemistry in Marburg, Germany and received his doctorate from the Max-Planck Institute of Polymer Research in Mainz. He finished his Post-doc at the Harvard University in Boston, USA. In 2011 Buchholz was appointed honorary professor by the University of Stuttgart. Prof. Buchholz began his professional career within Evonik in 1993 as scientific assistant in the business unit Industry and Fine Chemicals of the former Degussa in Frankfurt. From 1998 to 2000 he worked as plant assistant at the Antwerp, Belgium site before he took over management of the Biotechnology Project House at the Hanau site. From 2008 until recently, Prof. Buchholz was Head of Innovation Management in the business unit Advanced Intermediates.

Company

Logo:

Evonik Industries AG

Rellinghauser Straße 1-11
45128 Essen
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.